Filing Details
- Accession Number:
- 0000899243-21-008434
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-26 17:11:26
- Reporting Period:
- 2021-02-25
- Accepted Time:
- 2021-02-26 17:11:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1501134 | Invitae Corp | NVTA | Services-Medical Laboratories (8071) | 271701898 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1689575 | Katherine Stueland | C/O Invitae Corporation 1400 16Th Street San Francisco CA 94103 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-02-25 | 5,000 | $10.23 | 208,052 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-25 | 1,100 | $38.95 | 206,952 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-25 | 2,300 | $39.65 | 204,652 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-25 | 1,300 | $40.97 | 203,352 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-25 | 300 | $41.75 | 203,052 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Options (Right to Buy) | Disposition | 2021-02-25 | 5,000 | $0.00 | 5,000 | $10.23 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 35,000 | 2026-03-31 | No | 4 | M | Direct |
Footnotes
- Includes an aggregate of 166,973 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- These sales of common stock were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on September 15, 2020.
- Represents a weighted average sale price. Actual sale prices ranged from $38.34 to $39.29 per share.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Represents a weighted average sale price. Actual sale prices ranged from $39.34 to $40.25 per share.
- Represents a weighted average sale price. Actual sale prices ranged from $40.45 to $41.28 per share.
- Represents a weighted average sale price. Actual sale prices ranged from $41.56 to $42.12 per share.
- The shares subject to this option are fully vested and exercisable.
Billionaire Hedge Funds
